Successful Treatment of a Patient with Drug-Refractory Rheumatoid Arthritis-Associated Interstitial Lung Disease with Upadacitinib: A Case Report

Successful Treatment of a Patient with Drug-Refractory Rheumatoid Arthritis-Associated Interstitial Lung Disease with Upadacitinib: A Case Report

Insufficient evidence exists regarding the efficacy of Janus kinase inhibitors (JAKis), a class of targeted synthetic disease-modifying anti-rheumatic drugs (tsDMARDs), in the treatment of rheumatoid arthritis (RA)-associated interstitial lung disease (ILD). Herein, we present a case of RA-ILD refra...

Full description

Bibliographic Details
Main Authors: Yuuya Nishii, Masaki Okamoto, Yoshiaki Zaizen, Takashi Kojima, Takashi Nouno, Yoshiko Naitou-Nishida, Norikazu Matsuo, Hiroaki Takeoka, Motoko Ishida, Masataka Nakamura, Toru Masuda, Takafumi Tanaka, Tomoya Miyamura, Tomoaki Hoshino
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Medicina
Subjects:
interstitial lung disease
rheumatoid arthritis
Janus kinase inhibitor
upadacitinib
Online Access:https://www.mdpi.com/1648-9144/59/11/1960

Internet

https://www.mdpi.com/1648-9144/59/11/1960

Similar Items